Chataway J - Search Results

1

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen.

Chataway J, Feakes R, Coraddu F, Gray J, Deans J, Fraser M, Robertson N, Broadley S, Jones H, Clayton D, Goodfellow P, Sawcer S, Compston A. Chataway J, et al. Brain. 1998 Oct;121 ( Pt 10):1869-87. doi: 10.1093/brain/121.10.1869. Brain. 1998. PMID: 9798743 Review.

2

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22.

Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. Sawcer S, et al. Among authors: chataway j. Nat Genet. 1996 Aug;13(4):464-8. doi: 10.1038/ng0896-464. Nat Genet. 1996. PMID: 8696343

3

Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis.

Robertson NP, O'Riordan JI, Chataway J, Kingsley DP, Miller DH, Clayton D, Compston DA. Robertson NP, et al. Among authors: chataway j. Lancet. 1997 May 31;349(9065):1587-90. doi: 10.1016/s0140-6736(96)07317-5. Lancet. 1997. PMID: 9174560

4

Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster.

Feakes R, Chataway J, Sawcer S, Jones HB, Clayton D, Goodfellow PN, Compston A. Feakes R, et al. Among authors: chataway j. Ann Neurol. 1998 Dec;44(6):984. doi: 10.1002/ana.410440622. Ann Neurol. 1998. PMID: 9851448 No abstract available.

5

HLA typing in the United Kingdom multiple sclerosis genome screen.

Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A. Coraddu F, et al. Among authors: chataway j. Neurogenetics. 1998 Dec;2(1):24-33. doi: 10.1007/s100480050048. Neurogenetics. 1998. PMID: 9933297

6

Exploring the dense mapping of a region of potential linkage in complex disease: an example in multiple sclerosis.

Feakes R, Sawcer S, Chataway J, Coraddu F, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A. Feakes R, et al. Among authors: chataway j. Genet Epidemiol. 1999;17(1):51-63. doi: 10.1002/(SICI)1098-2272(1999)17:1<51::AID-GEPI4>3.0.CO;2-V. Genet Epidemiol. 1999. PMID: 10323184

7

Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis.

Chataway J, Sawcer S, Coraddu F, Feakes R, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. Chataway J, et al. Neurogenetics. 1999 Apr;2(2):91-6. doi: 10.1007/s100480050058. Neurogenetics. 1999. PMID: 10369884

8

A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis.

Chataway J, Sawcer S, Feakes R, Coraddu F, Broadley S, Jones HB, Clayton D, Gray J, Goodfellow PN, Compston A. Chataway J, et al. J Neuroimmunol. 1999 Aug 3;98(2):208-13. doi: 10.1016/s0165-5728(99)00089-2. J Neuroimmunol. 1999. PMID: 10430054

9

More evidence that founder effects exist in the European population.

Chataway J, Sawcer S, Feakes R, Coraddu F, Broadley S, Gray J, Compston A. Chataway J, et al. Eur J Hum Genet. 1999 Sep;7(6):623-4. doi: 10.1038/sj.ejhg.5200357. Eur J Hum Genet. 1999. PMID: 10482948 No abstract available.

10

No evidence for association of multiple sclerosis with the complement factors C6 and C7.

Chataway J, Sawcer S, Sherman D, Hobart M, Fernie B, Coraddu F, Feakes R, Broadley S, Gray J, Jones HB, Clayton D, Goodfellow PN, Compston A. Chataway J, et al. J Neuroimmunol. 1999 Sep 1;99(1):150-6. doi: 10.1016/s0165-5728(99)00054-5. J Neuroimmunol. 1999. PMID: 10496188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters